159 related articles for article (PubMed ID: 37404092)
1. An injectable supramolecular hydrogel as a self-drug-delivery system for local chemoimmunotherapy against melanoma.
Bera S; Datta HK; Dastidar P
Biomater Sci; 2023 Aug; 11(16):5618-5633. PubMed ID: 37404092
[TBL] [Abstract][Full Text] [Related]
2. Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy.
Song H; Yang P; Huang P; Zhang C; Kong D; Wang W
Theranostics; 2019; 9(8):2299-2314. PubMed ID: 31149045
[TBL] [Abstract][Full Text] [Related]
3. An injectable thermosensitive hydrogel/nanomicelles composite for local chemo-immunotherapy in mouse model of melanoma.
Akbari V; Hejazi E; Minaiyan M; Emami J; Lavasanifar A; Rezazadeh M
J Biomater Appl; 2022 Sep; 37(3):551-562. PubMed ID: 35543695
[TBL] [Abstract][Full Text] [Related]
4. Functionalized Caprolactone-Polyethylene Glycol Based Thermo-Responsive Hydrogels of Silibinin for the Treatment of Malignant Melanoma.
Makhmalzadeh BS; Molavi O; Vakili MR; Zhang HF; Solimani A; Abyaneh HS; Loebenberg R; Lai R; Lavasanifar A
J Pharm Pharm Sci; 2018; 21(1):143-159. PubMed ID: 29789104
[TBL] [Abstract][Full Text] [Related]
5. Sericin/Dextran Injectable Hydrogel as an Optically Trackable Drug Delivery System for Malignant Melanoma Treatment.
Liu J; Qi C; Tao K; Zhang J; Zhang J; Xu L; Jiang X; Zhang Y; Huang L; Li Q; Xie H; Gao J; Shuai X; Wang G; Wang Z; Wang L
ACS Appl Mater Interfaces; 2016 Mar; 8(10):6411-22. PubMed ID: 26900631
[TBL] [Abstract][Full Text] [Related]
6. Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel.
Dai X; Meng J; Deng S; Zhang L; Wan C; Lu L; Huang J; Hu Y; Zhang Z; Li Y; Lovell JF; Wu G; Yang K; Jin H
Theranostics; 2020; 10(7):3049-3063. PubMed ID: 32194854
[TBL] [Abstract][Full Text] [Related]
7. Supramolecular assembly of a trivalent peptide hydrogel vaccine for cancer immunotherapy.
Song H; Su Q; Nie Y; Zhang C; Huang P; Shi S; Liu Q; Wang W
Acta Biomater; 2023 Mar; 158():535-546. PubMed ID: 36632876
[TBL] [Abstract][Full Text] [Related]
8. In situ injectable hydrogel-loaded drugs induce anti-tumor immune responses in melanoma immunochemotherapy.
Li J; Luo G; Zhang C; Long S; Guo L; Yang G; Wang F; Zhang L; Shi L; Fu Y; Zhang Y
Mater Today Bio; 2022 Mar; 14():100238. PubMed ID: 35330634
[TBL] [Abstract][Full Text] [Related]
9. Topical CpG enhances the response of murine malignant melanoma to dacarbazine.
Najar HM; Dutz JP
J Invest Dermatol; 2008 Sep; 128(9):2204-10. PubMed ID: 18368132
[TBL] [Abstract][Full Text] [Related]
10. Research progress on hydrogel-based drug therapy in melanoma immunotherapy.
He W; Zhang Y; Qu Y; Liu M; Li G; Pan L; Xu X; Shi G; Hao Q; Liu F; Gao Y
BMB Rep; 2024 Feb; 57(2):71-78. PubMed ID: 38053295
[TBL] [Abstract][Full Text] [Related]
11. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.
Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D
J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064
[TBL] [Abstract][Full Text] [Related]
12. Injectable polypeptide hydrogel for dual-delivery of antigen and TLR3 agonist to modulate dendritic cells in vivo and enhance potent cytotoxic T-lymphocyte response against melanoma.
Song H; Huang P; Niu J; Shi G; Zhang C; Kong D; Wang W
Biomaterials; 2018 Mar; 159():119-129. PubMed ID: 29324304
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-15 and cisplatin co-encapsulated thermosensitive polypeptide hydrogels for combined immuno-chemotherapy.
Wu X; Wu Y; Ye H; Yu S; He C; Chen X
J Control Release; 2017 Jun; 255():81-93. PubMed ID: 28408199
[TBL] [Abstract][Full Text] [Related]
14. Injectable hydrogels of newly designed brush biopolymers as sustained drug-delivery vehicle for melanoma treatment.
Shukla A; Singh AP; Maiti P
Signal Transduct Target Ther; 2021 Feb; 6(1):63. PubMed ID: 33589586
[TBL] [Abstract][Full Text] [Related]
15. Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel.
Jin H; Wan C; Zou Z; Zhao G; Zhang L; Geng Y; Chen T; Huang A; Jiang F; Feng JP; Lovell JF; Chen J; Wu G; Yang K
ACS Nano; 2018 Apr; 12(4):3295-3310. PubMed ID: 29558107
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Transdermal Drug Delivery by Transfersome-Embedded Oligopeptide Hydrogel for Topical Chemotherapy of Melanoma.
Jiang T; Wang T; Li T; Ma Y; Shen S; He B; Mo R
ACS Nano; 2018 Oct; 12(10):9693-9701. PubMed ID: 30183253
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic supramolecular tubustecan hydrogel combined with checkpoint inhibitor elicits immunity to combat cancer.
Wang F; Su H; Xu D; Monroe MK; Anderson CF; Zhang W; Oh R; Wang Z; Sun X; Wang H; Wan F; Cui H
Biomaterials; 2021 Dec; 279():121182. PubMed ID: 34688987
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide inhibits melanoma in vitro and in vivo.
Scatozza F; Moschella F; D'Arcangelo D; Rossi S; Tabolacci C; Giampietri C; Proietti E; Facchiano F; Facchiano A
J Exp Clin Cancer Res; 2020 Oct; 39(1):211. PubMed ID: 33028392
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of paracrine immunotherapy in experimental brain tumors.
Lesniak MS; Sampath P; DiMeco F; Viglione MP; Tyler BM; Pardoll DM; Brem H
Neurosurg Focus; 2000 Dec; 9(6):e4. PubMed ID: 16817687
[TBL] [Abstract][Full Text] [Related]
20. USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity.
Hong B; Li H; Lu Y; Zhang M; Zheng Y; Qian J; Yi Q
Mol Cancer; 2014 May; 13():132. PubMed ID: 24884733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
